David A Rosa Neuroone Medical Technologies Corp (NMTC) insider trading activity

NMTC Quotes by TradingView

David A Rosa is CEO and President of NEUROONE MEDICAL TECHNOLOGIES Corp. Currently has a direct ownership of 1.14 Million shares of NMTC, which is worth approximately $1.08 Million. The most recent transaction as insider was on Feb 03, 2022, when has been sold 250,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.14M
0.8% 3M change
115.0% 12M change
Total Value Held $1.08 Million

David A Rosa Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 03 2022
BUY
Grant, award, or other acquisition
-
250,000 Added 32.7%
514,608 Common Stock

Also insider at

BTCY
BIOTRICITY INC. Healthcare
Director
BRTX
BioRestorative Therapies, Inc. Healthcare
HCTI
Healthcare Triangle, Inc. Healthcare
Director
DAR

David A Rosa

CEO and President
Pleasanton, CA

Track Institutional and Insider Activities on NMTC

Follow NEUROONE MEDICAL TECHNOLOGIES Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NMTC shares.

Notify only if

Insider Trading

Get notified when an Neuroone Medical Technologies Corp insider buys or sells NMTC shares.

Notify only if

News

Receive news related to NEUROONE MEDICAL TECHNOLOGIES Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NMTC